Please wait a minute...
European Journal of Gynaecological Oncology  2019, Vol. 40 Issue (4): 614-618    DOI: 10.12892/ejgo4553.2019
Original Research Previous articles | Next articles
Histopathologic features of advanced stage endometrial carcinoma
S. Kabukcuoglu1, *(), B. Hayit1
1 Department of Pathology, The University of Eskisehir Osmangazi School of Medicine, Eskisehir, Turkey
Download:  PDF(1114KB)  ( 194 ) Full text   ( 7 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Objectives: Four to six percent of endometrial cancer (EC) cases have been diagnosed at an advanced stage. The aim of the study is to show the role of immunohistochemistry in the new endometrial carcinoma classification. Materials and Methods: Twenty-nine advanced Stage EC cases which were admitted to the Eskisehir Osmangazi Hospital were included in the study. One grade 1, 18 grade 2, and ten grade 3 EC cases were detected. Ten EC cases showed focal or diffuse strong p53 expression and three cases had Lynch syndrome with the dual loss of MLH1 and PMS2. In those cases that were above 60-years-old, PTEN inactivation, loss of PAX-8, and strong p16 positivity were detected. Five cases had focal or complete e-cadherin loss or inactivation and ten cases had focal CDX-2 expression and/or β cathenin nuclear expression due to β-cathenin mutation. Results: Nine out of 22 cases who had deep myometrial invasion showed MELF pattern of myometrial invasion (p = 0.05). Fallopian tube involvements were associated with mild p53 positivity (p = 0.002) and peritoneal washing fluid positivities were correlated with serosal involvement (p = 0.013). Three cases (10.3%) showed recurrences and one case died from the disease during the study. Conclusions: Tubal endometriosis or adenomyomatous polyp were found in the other tube in ECs with tubal involvement and these case had superficial myometrial invasion. Strong p53 expression and Lynch syndrome coexisted with the e-cadherin and β-cathenin mutations in advanced stage ECs.
Key words:  Endometrial cancer      Immunohistochemistry      p53      MLH1      Advanced stage      Endometriosis     
Published:  10 August 2019     
*Corresponding Author(s):  S. KABUKCUOGLU     E-mail:  skabukcuoglu@hotmail.com

Cite this article: 

S. Kabukcuoglu, B. Hayit. Histopathologic features of advanced stage endometrial carcinoma. European Journal of Gynaecological Oncology, 2019, 40(4): 614-618.

URL: 

https://ejgo.imrpress.com/EN/10.12892/ejgo4553.2019     OR     https://ejgo.imrpress.com/EN/Y2019/V40/I4/614

[1] Ikuji Shimazaki, Yasunori Hashiguchi, Makoto Yamauchi, Mari Kasai, Takeshi Fukuda, Tomoyuki Ichimura, Tomoyo Yasui, Toshiyuki Sumi. Secondary small cell vaginal cancer after operative therapy for endometrial cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 821-823.
[2] Jaudah Al-Maghrabi, Haneen Al-Maghrabi. SIRT1 is overexpressed in endometrial adenocarcinoma: a tissue microarray analysis[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 699-704.
[3] Yu Hui Lim, Sheow Lei Lim, Linda Xiao Hui Lin, Lay Tin Soh, Hoon Seng Khoo Tan, Richard Ming Chert Yeo, Timothy Yong Kuei Lim. Sequential Chemoradiation versus Radiation for the Adjuvant Treatment of Stage III Endometrioid Adenocarcinoma of the Uterus[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 705-712.
[4] Eda Kucuktulu, Ahmet Fatih Yurekli. Simultaneous Integrated Intensity Modulated Radiotherapy Boost for Gynecological Cancer when Brachytherapy is not an Option[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 720-725.
[5] Wook Youn Kim, Shin Hee Seo, Seung-Hyuk Shim, Jin Hee Park, Hyung Kyu Park, Kyeong A So, Tae Jin Kim, Sun Joo Lee. Correlation of immunohistochemistry and silver in situ hybridization for the assessment of c-MET in uterine cervical cancer patients treated with radical hysterectomy[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 745-752.
[6] Michelle F. Benoit, Kristy K. Ward. Uterine Cancer Normogram to Predict Lymph Node Metastasis: Comparison to the Mayo Algorithm and an External Validation of a Model in a North American Population[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 681-684.
[7] Hyang Sook Jeong, Yuki Gen, Hui Ryun Joo, Ji Geun Yoo, Seung Geun Yeo, Dong Choon Park. Mesonephric-like carcinoma of the uterine corpus: A case report and literature review[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 664-667.
[8] Yusuf Cakmak, Tufan Oge. The effect of age on prediction of concurrent endometrial cancer in patients with atypical endometrial hyperplasia[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 531-535.
[9] Sigit Purbadi, Gregorius Tanamas, Lisa Novianti. Advanced stage ovarian cancer survival in Jakarta[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 587-590.
[10] Di Wu, Jirui Zhang, Chengxi Yang. Effect of letrozole combined with testosterone on the proliferation and apoptosis of endometrial carcinoma cells[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 604-608.
[11] Soo-Young Lee, Dae-Hyung Lee. Perivascular epithelioid cell tumor arising in the left parametrium: a case report[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 657-660.
[12] B.-H. Zhang, L. Li, J. Ji, J. Guo, X.-L. Zhou, H. Xu, F. Cao, X.-H. Tong. Prognostic value of Foxp3+ regulatory T cells in endometrial cancer: a meta-analysis[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 339-342.
[13] Marcin Jedryka, Agnieszka Chrobak, Anna Chelmonska-Soyta, Daria Fijalkowska, Rafal Matkowski. Decreased expression of estrogen receptors alpha and beta in peripheral blood lymphocytes from the endometrial cancer patients and women with endometriosis[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 375-379.
[14] J.Y. Chen, Z.Q. Wang, S.C. Liang, H.Y. Hou, D.B. Chen, J.L. Wang. Sentinel lymph node mapping with carbon nanoparticles in endometrial cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 408-414.
[15] J. Feng, J. Wu, M. Zhang, J. Wang, K. Chen, X. Li, J. Xie, J. Zhang, C. Wang. Oleic acid promotes the development of endometrial cancer by up-regulating KLF4 expression[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 432-438.
No Suggested Reading articles found!